Mold-Tek Packaging Limited has informed the Exchange about Transcript
MOLDTKPAC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mold-Tek Packaging reported strong Q4 FY26 results with 13.4% full-year sales growth. Pharma segment surged over 200% to INR34.3 crores, while Paint grew double-digits and Food/FMCG expanded 15%. The company consolidated 5 Hyderabad units into 2, improving EBITDA margins to 40.7 per kg. Management guided for FY27 revenue crossing INR1,000 crores with 13-15% value growth and EBITDA of INR210 crores (up 20%). Capacity is expected to reach 67,000-68,000 MTPA by FY27 end with capex of INR80-85 crores. Lubes segment declined due to loss of BPCL business (INR14-15 crores). Management targets EBITDA per kg of 42.5-43 for FY27 and sees margin improvement continuing from consolidation benefits.
Positive for shareholders as management maintained margin improvement trajectory and guided for 20% EBITDA growth in FY27. The stock could see re-rating as ROCE recovers from current 12.4% toward 15% by FY27-28 as capacity utilization improves.